Dynavax (DVAX) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
Other income (expense): -26K
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Other income (expense): -26K
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.15 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Truist Names Top Infrastructure Services Stocks
- ImmuCell reports 46% sales increase in Q3 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
